2064-1373 Screening compound: 1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-1,2,3-triazole-5-carbohydrazide

2064-1373 Screening compound: 1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-1,2,3-triazole-5-carbohydrazide
2064-1373 Screening compound: 1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-1,2,3-triazole-5-carbohydrazide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2064-1373
1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-1,2,3-triazole-5-carbohydrazide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2064-1373

Molecular Formula

C20H17N9O5 (C20 H17 N9 O5)

Compound Name

1-(4-amino-1,2,5-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-1,2,3-triazole-5-carbohydrazide

IUPAC name

1-(4-amino-125-oxadiazol-3-yl)-N'-[(E)-(2-ethoxyphenyl)methylidene]-4-(4-nitrophenyl)-1H-123-triazole-5-carbohydrazide

SMILES

CCOc1c(/C=N/NC(c2c(-c(cc3)ccc3[N+]([O-])=O)nnn2-c2nonc2N)=O)cccc1

InChI

InChI=1S/C20H17N9O5/c1-2-33-15-6-4-3-5-13(15)11-22-24-20(30)17-16(12-7-9-14(10-8-12)29(31)32)23-27-28(17)19-18(21)25-34-26-19/h3-11H,2H2,1H3,(H2,21,25)(H,24,30)

InChI Key

QDBFCMKJZKEHJU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01839570

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.41

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

14

Partition Coefficient, logP

3.400

Distribution Coefficient, logD

3.400

Water Solubility, LogSw

-3.75

Polar Surface Area

157.994

Acid Dissociation Constant (pKa)

10.82

Base Dissociation Constant (pKb)

3.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

10.00

2064-1373 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 2064-1373 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2064-1373?
Check Price and Availability of 2064-1373, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2064-1373 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2064-1373
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2064-1373
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2064-1373 available by request